ArticleDiscover oncology2026
Rectal diffuse large B-cell lymphoma misdiagnosed as bleeding cancer in an elderly patient.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPrimary rectal diffuse large B-cell lymphoma (DLBCL) is a rare malignancy that often closely mimics more common rectal pathologies such as adenocarcinoma or inflammatory bowel disease. This resemblance poses considerable diagnostic difficulty, and misdiagnosis may result in delayed treatment and unnecessary procedures, ultimately affecting patient outcomes. CASE PRESENTATION: An 87-year-old female presented with intermittent hematochezia that acutely worsened two hours before admission. Physical examination identified a rectal mass located 5 cm from the anal verge. Pelvic imaging and colonoscopy were suggestive of hemorrhagic adenocarcinoma. Given the patient’s advanced age, significant anemia, and elevated bleeding risk, a multidisciplinary team decided against preoperative biopsy. Instead, transanal minimally invasive surgery was carried out for local disease control. Final histopathological analysis of the resection specimen revealed DLBCL, germinal center B-cell-like subtype. Following surgery, the patient was referred to hematology for guideline-directed chemotherapy and remained free of recurrence during follow-up.
conclusionThis case highlights that rectal DLBCL can present with hematochezia as the sole symptom and may be mistaken for rectal adenocarcinoma, particularly in elderly patients. The divergence between the preoperative clinical impression and the postoperative pathological diagnosis emphasizes both the diagnostic challenge and the tailored therapeutic approach required for this rare condition. A high index of suspicion for uncommon malignancies is crucial to ensure appropriate clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.